Biomarkers of glioblastoma multiforme
- 1 March 2015
- journal article
- review article
- Published by Elsevier BV in Metabolism
- Vol. 64 (3), S22-S27
- https://doi.org/10.1016/j.metabol.2014.10.031
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Selection of DNA Aptamers against Glioblastoma Cells with High Affinity and SpecificityPLOS ONE, 2012
- Integrative Genomics Viewer (IGV): high-performance genomics data visualization and explorationBriefings in Bioinformatics, 2012
- Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastomaNeuro-Oncology, 2012
- Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1European Journal Of Cancer, 2010
- The Value of 99mTc-Tetrofosmin Brain SPECT in Predicting Survival in Patients with Glioblastoma MultiformeJournal of Nuclear Medicine, 2010
- Correlation of MIB-1 staining index and 201Tl-SPECT retention index in preoperative evaluation of malignancy of brain tumorsBrain Tumor Pathology, 2010
- O 6-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastomaInternational Journal of Clinical Oncology, 2010
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- Rembrandt: Helping Personalized Medicine Become a Reality through Integrative Translational ResearchMolecular Cancer Research, 2009
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008